BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29424867)

  • 21. Static Prognostic Factors and Appropriate Surgical Designs for Patients with Medullary Thyroid Carcinoma: The Second Report from a Single-Institution Study in Japan.
    Ito Y; Miyauchi A; Kihara M; Higashiiyama T; Fukushima M; Miya A
    World J Surg; 2018 Dec; 42(12):3954-3966. PubMed ID: 30051240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Jin LX; Moley JF
    Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demographic, clinical, and genetic characteristics of patients with medullary thyroid cancer in the past 16 years in Castilla-La Mancha.
    Louhibi L; Marco A; Pinés PJ; Padillo JC; Gómez I; Valero MA; Alramadán M; Herranz S; Aguirre M; Hernández A
    Endocrinol Nutr; 2014 Oct; 61(8):398-403. PubMed ID: 24794695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis.
    Herac M; Niederle B; Raderer M; Krebs M; Kaserer K; Koperek O
    APMIS; 2016 Oct; 124(10):839-45. PubMed ID: 27539746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PROGNOSTIC VARIABLES AFFECTING PRIMARY TREATMENT OUTCOME FOR MEDULLARY THYROID CANCER.
    Momin S; Chute D; Burkey B; Scharpf J
    Endocr Pract; 2017 Sep; 23(9):1053-1058. PubMed ID: 28683235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
    Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
    Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
    Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
    Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
    Feng M; Zou J; Zhang Y; Sun L
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical challenges with calcitonin-negative medullary thyroid carcinoma.
    Samà MT; Rossetto Giaccherino R; Gallo M; Felicetti F; Maletta F; Bonelli N; Piovesan A; Palestini N; Ghigo E; Arvat E
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):2023-9. PubMed ID: 27125958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anaplastic carcinoma of the thyroid at the Instituto Nacional de la Nutrición Salvador Zubirán].
    Sierra M; Gamboa-Domínguez A; Herrera MF; Barredo-Prieto B; Alvarado de la Barrera C; Llorente L; Pérez-Enriquez B; Rivera R; González O; Rull JA
    Rev Invest Clin; 1997; 49(2):97-103. PubMed ID: 9380971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Patterns of Distant Metastases in Follicular, Papillary and Medullary Thyroid Cancer.
    Machens A; Lorenz K; Weber F; Dralle H
    Horm Metab Res; 2022 Jan; 54(1):7-11. PubMed ID: 34758495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological features and prognostic factors analysis of multiple synchronous distinct subtypes of primary thyroid carcinoma.
    Dai Q; Fu X; Ding Y; He Q; Qiu X
    Endocrine; 2023 Mar; 79(3):491-501. PubMed ID: 36399310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent disease and recurrence in medullary thyroid carcinoma: A case series.
    Tejera Hernández AA; Gutiérrez Giner MI; Rocca Cárdenas JC; Rodríguez Rodríguez F; Hernández Hernández JR
    Cir Esp (Engl Ed); 2019 Apr; 97(4):234-237. PubMed ID: 30482582
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
    Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
    Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.